Abstract
Background The number of publicly reported deaths from COVID-19 may underestimate the true death toll from the epidemic as they rely on provisional data that are often incomplete or omit undocumented deaths from COVID-19. In addition, these reports may be subject to significant under-reporting due to a limited testing capacity of a country to identify suspect cases. This study estimated the number of seasonal excess deaths attributable to the COVID-19 epidemic in 31 provinces of Iran.
Methods We gathered the nationwide and provincial time series of the seasonal all-cause mortality data from spring 2015 to summer 2020 (21 March 2015 to 21 September 2020), in accordance with the Solar Hijri (SH) calendar, from the National Organization for Civil Registration (NOCR). We estimated the expected number of seasonal deaths for each province using a piecewise linear regression model which we established based on the mortality figures for the previous years and considered any significant deviations from the expectation during winter, spring, and summer of 2020 to be directly associated with COVID-19.
Results Our analysis shows that from the start of winter to the end of summer (from 22 December 2019 to 21 September 2020), there were a total of 58.9K (95%CI: 46.9K - 69.5K) excess deaths across all 31 provinces with 27% (95%CI: 20% - 34%) estimated nationwide exposure to SARS-CoV-2. In particular, 2 provinces in the central and northern Iran, namely Qom and Golestan, had the highest level of exposure with 57% (95%CI: 44% - 69%) and 56% (95%CI: 44% - 69%), respectively, while another 27 provinces had significant levels of excess mortality in at least one season with >20% population-level exposure to the virus. We also detected unexpectedly high levels of excess mortality during fall 2019 (from 23 September to 21 December 2019) across 18 provinces. Our findings suggest that this spike cannot be a result of an early cryptic transmission of COVID-19 across the country and is also inconsistent with the molecular phylogenetics estimates for the start of the pandemic and its arrival to Iran. However, in the absence of appropriate surveillance data for detecting severe acute respiratory infections we were unable to make a determination as to what caused the spike in fall 2019.
Conflict of Interest None.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MG is funded by the Biotechnology and Biological Science Research Council (BBSRC), grant number BB/M011224/1.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
no IRB required for this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the datasets used in this study are publicly available at the National Organization for Civil Registration (NOCR) and can be found on sabteahval.ir website.
